AZD 2098
Chemical Name: 2,3-Dichloro-N-(3-methoxy-2-pyrazinyl)benzenesulfonamide
Purity: ≥98%
Biological Activity
AZD 2098 is a potent and selective CCR4 antagonist (pIC50 = 7.8). Exhibits no activity at CXCR1 and CXCR2, CCR1, CCR2b, CCR5, CCR7, and CCR8 at 10 μM, and no significant activity when screened against a panel of 120 receptors and enzymes. Inhibits CCL22 Ca2+ response and Th2 cell CCL17/22 driven chemotaxis in vitro. Inhibits lung inflammation following antigen challenge in ovalbumin- sensitized rats.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Small molecule immuno-oncology therapeutic agents.
Toogood et al.
Bioorg.Med.Chem.Lett., 2017;S0960:31218 -
Discovery of AZD-2098 and AZD-1678, two potent and bioavailable CCR4 receptor antagonists.
Kindon et al.
ACS Med.Chem.Lett., 2017;8:981 -
Cancer charity sees success re-prioritizing industry's shelved compounds.
Mullard et al.
Nat.Rev.Drug Discov., 2014;13:319
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for AZD 2098
There are currently no reviews for this product. Be the first to review AZD 2098 and earn rewards!
Have you used AZD 2098?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
